Jewish General Hospital / McGill University

Montreal, Quebec H3T 1E2

0 studies enrolling now · 7 studies all time

What they study most

Alzheimer's Disease, Leukemia, Myeloid, Acute, Mild Cognitive Impairment, Neoplasms, Myelogenous Leukemia, Acute, Prostate Cancer, Solid Tumors

Studies at this site

• A Study of Gantenerumab in Participants With Mild Alzheimer Disease — Completed
• A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease — Stopped early
• A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors — Completed
• A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy — Completed
• A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors — Completed
• A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia. — Completed
• Alzheimer's Disease Neuroimaging Initiative Grand Opportunity — Completed